# ELIXIRGEN THERAPEUTICS, INC. — Form D

ELIXIRGEN THERAPEUTICS, INC. of BALTIMORE, MD, a company, filed a Form D exempt-offering notice with the SEC on 2025-04-09. The offering totals $3.6M, of which $3.6M was reported sold. Industry: Biotechnology.

## Offering

- Filed: 2025-04-09
- Form: D
- Accession: 0001744333-25-000002
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $3.6M
- Amount sold: $3.6M
- Investors: 2
- Date of first sale: 2025-03-31
- Security types: debt
- Revenue range: Decline to Disclose
- SEC file number: 021-543260

## Issuer

- Name: ELIXIRGEN THERAPEUTICS, INC.
- CIK: 0001744333
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2018
- Address: 855 N. WOLFE ST., BALTIMORE, MD, 21205
- Phone: 443-451-5300

## Officers, directors & promoters (18)

| Name | Role | Location |
| --- | --- | --- |
| HIROAKI KOBAYASHI | Director | BALTIMORE, MD |
| THOMAS WHITE | Director | BALTIMORE, MD |
| JEFFREY CLELAND | Director | BALTIMORE, MD |
| MINORU KO | Director | BALTIMORE, MD |
| MINORU KO | Executive Officer | BALTIMORE, MD |
| SHAUNA CALLAHAN | Director | BALTIMORE, MD |
| AKIHIRO KO | Director | BALTIMORE, MD |
| AKIHIRO KO | Executive Officer | BALTIMORE, MD |
| AKIHIRO KO | Promoter | BALTIMORE, MD |
| Akihiro C Ko | Director | Baltimore, MD |
| Akihiro C Ko | Executive Officer | Baltimore, MD |
| Minoru SH Ko | Director | Baltimore, MD |
| Hiroaki C Kobayashi | Director | Baltimore, MD |
| Thomas K White | Director | Baltimore, MD |
| Shauna K Callahan | Director | Baltimore, MD |
| Jeffrey K Cleland | Director | Baltimore, MD |
| Maiko Katadae | Director | Baltimore, MD |
| Naonori Kurokawa | Director | Baltimore, MD |

## Other filings by this issuer (8)

| Filed | Form | Offering | Sold |
| --- | --- | --- | --- |
| [2025-11-13](https://search.stillhousedata.com/formd/0001744333-25-000004) | D | $4.0M | $4.0M |
| [2025-02-12](https://search.stillhousedata.com/formd/0001744333-25-000001) | D | $600K | $600K |
| [2023-12-01](https://search.stillhousedata.com/formd/0001744333-23-000001) | D | $7.0M | $7.0M |
| [2022-09-29](https://search.stillhousedata.com/formd/0001744333-22-000001) | D | $5.0M | $5.0M |
| [2021-02-18](https://search.stillhousedata.com/formd/0001744333-21-000003) | D | $5.5M | $4.2M |
| [2020-08-17](https://search.stillhousedata.com/formd/0001744333-20-000001) | D/A | $5.7M | $5.7M |
| [2019-12-02](https://search.stillhousedata.com/formd/0001744333-19-000001) | D | $5.0M | $5.0M |
| [2018-06-25](https://search.stillhousedata.com/formd/0001744333-18-000001) | D | $4.0M | $4.0M |

## More

- [CIK 1744333 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1744333&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0001744333-25-000002.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.